Skip to main content

stock

ACBM · ACRO BIOMEDICAL CO., LTD.

What ACRO BIOMEDICAL CO., LTD. reports to the SEC, read from its filings.

Open in the app

Price

The live ACBM price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on ACBM.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Services-Amusement & Recreation Services (SIC 7900)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
60,042,000 as of 2026-08-05 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
—
ROA
-3849.0%

Health

Current ratio
0.0x
Debt/equity
—

Deep value

NCAV
—
NCAV per share
—
Price/NCAV
Locked
NNWC
—
NNWC per share
—
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30$0—-$17,554-$21,356
10-Q filed 2026-08-14
2026-03-31$0—-$60,271-$43,774
10-Q filed 2026-08-14
Assembled from more than one filing; the filing above is only the newest of them.
2025-12-31$0—-$16,377$42,526
10-K filed 2026-02-11
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30$0—-$115,099-$117,809
10-Q filed 2025-11-10
2025-06-30$0—-$13,614-$15,562
10-Q filed 2026-08-14
2025-03-31$0—-$8,934-$10,301
10-Q filed 2026-08-14
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31$0—-$9,468-$10,673
10-K filed 2026-02-11
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30$0—-$9,106-$10,229
10-Q filed 2025-11-10
Assets
$3,648
Equity
-$444,789

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$0-$154,024-$101,146—
2024-12-31$0-$37,958-$42,297—
2023-12-31$0-$8.80M-$8.81M—
2022-12-31$658,500-$15.87M-$15.87M—
2021-12-31$1.20M-$7.69M-$7.70M—
2020-12-31$687,964-$130,463-$117,453—
2019-12-31$193,536-$422,751-$371,604—
2019-09-30$1.35M-$441,553-$370,747—
2018-09-30$8.01M$515,550$419,660—
2017-09-30$510,000-$2,248-$2,248—

Company filings

Insiders, politicians and funds

Insider trades, last 90 days

Politician trades, last 90 days

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named ACBM, and the market events around them.

Sign in to see this

Board

The ACBM board could not be loaded.

Retry the ACBM board

nakagai

Signals on ACBM come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the ACBM board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

ACRO BIOMEDICAL CO., LTD. (ACBM): SEC filings, financials and insider trades · Nakagai